Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.
胰高血糖素樣肽-1 受體激動劑圍手術管理的社會指導比較：對臨床實踐和未來研究的影響。
Can J Anaesth 2024-08-26
Should We Stop Glucagon-Like Peptide-1 Receptor Agonists Before Surgical or Endoscopic Procedures? Balancing Limited Evidence With Clinical Judgment.
手術或內視鏡檢查前，我們應該停止使用胰高血糖素樣肽-1受體激動劑嗎？在有限證據與臨床判斷之間取得平衡。
J Diabetes Sci Technol 2024-03-11
美國麻醉醫學學會建議手術前停用GLP-1 RA，以免誤吸風險，但證據有限。停用GLP-1 RA 可能影響糖尿病控制，需要更多研究評估風險。建議採取多學科方法管理接受GLP-1 RA治療的手術患者，並進行觀察性研究了解停用GLP-1 RA對誤吸風險和血糖控制的影響。
PubMedDOI
Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists.
接受胰高血糖素樣肽-1受體激動劑治療時進行上消化道內視鏡檢查的臨床結果和安全性。
Clin Gastroenterol Hepatol 2024-05-01
Glucagon-Like Peptide-1 Agonists and General Anesthesia: Perioperative Considerations and the Utility of Gastric Ultrasound.
GLP-1激動劑與全身麻醉：围手术期考虑因素及胃超声的效用。
Cureus 2024-05-14
Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.
葡萄糖樣肽-1 受體激動劑：臨床藥理學敘述性評論及對围手术期實踐的影響。
Anaesthesia 2024-05-13
Impact of glucagon-like peptide receptor agonists on endoscopy and its preoperative management: Guidelines, challenges, and future directions.
胰高血糖素樣肽受體激動劑對內視鏡檢查及其術前管理的影響：指引、挑戰與未來方向。
World J Gastrointest Endosc 2024-07-01
The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis.
在接受麻醉或鎮靜的患者中，胰高血糖素樣肽-1受體激動劑的影響：系統性回顧與統合分析。
Perioper Med (Lond) 2024-07-22
Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study.
在內視鏡程序前是否有必要停止使用胰高血糖素樣肽-1受體激動劑？一項回顧性研究。
World J Gastroenterol 2024-08-01